$Hepion Pharmaceuticals (HEPA.US)$Hepion Pharmaceuticals Announces Restructuring Plan To Enhance Shareholder Value And Management Changes; Reducing Operating Costs By ~60% Going Forward. Hepion Will Incur A One-Time Restructuring Charge Of ~$400K–$800K That Will Be Recorded In Q4 Of 2023
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more